GCG and type 2 diabetes mellitus: It is known that T2D is a chronic degenerative disease characterized by high risk of complications and an increasing social, economic and health burden worldwide (52, 53); on the other hand, GLP-1 therapy is recognized as one of the key strategies to overcome clinical inertia in cardiorenal protection of T2DM patients (53, 54).